Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Nov-23 9:21 PM View:  | Kayne Richard A 10% Owner | Eiger BioPharmaceuticals, I... (EIGR) | 02-Nov-23 | Purchase | 23,398 | $0.30 | $6,965.58 | < 1% 10.47M to 10.5M | |
| 02-Nov-23 9:21 PM View: | Kayne Richard A 10% Owner | Eiger BioPharmaceuticals, I... (EIGR) | 01-Nov-23 | Purchase | 100,000 | $0.28 | $27,970.00 | < 1% 10.37M to 10.47M | |
| 02-Nov-23 9:14 PM View: | Kawas Leen 10% Owner | Eiger BioPharmaceuticals, I... (EIGR) | 31-Oct-23 | Private Purchase | 24,332 | $0.26 | $6,374.80 | < 1% 4.37M to 4.39M | |
| 02-Nov-23 9:21 PM View: | Kayne Richard A 10% Owner | Eiger BioPharmaceuticals, I... (EIGR) | 31-Oct-23 | Private Purchase | 154,841 | $0.24 | $37,879.70 | 2% 10.22M to 10.37M | |
| 21-Mar-23 9:00 PM View: | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | Eiger BioPharmaceuticals, I... (EIGR) | 17-Mar-23 | Sale | 4,395 | $1.07 | $4,703.96 | (7%) 60.47K to 56.07K | |
| 25-Jan-23 8:54 PM View: | Dietz Thomas John Director | Eiger BioPharmaceuticals, I... (EIGR) | 23-Jan-23 | Private Purchase | 50,000 | $1.43 | $71,580.00 | 238% 21.0K to 71.0K | |
| 03-Jan-23 8:30 PM View: | Murray Christine Director | Eiger BioPharmaceuticals, I... (EIGR) | 29-Dec-22 | Sale | 5,000 | $1.22 | $6,104.00 | (31%) 16.0K to 11.0K | |
| 27-Dec-22 5:31 PM View: | Glenn Jeffrey S Director | Eiger BioPharmaceuticals, I... (EIGR) | 22-Dec-22 | Private Purchase | 100,000 | $1.28 | $127,950.00 | 42% 238.88K to 338.88K | |
| 27-Dec-22 5:31 PM View: | Dietz Thomas John Director | Eiger BioPharmaceuticals, I... (EIGR) | 22-Dec-22 | Sale | 22,500 | $1.17 | $26,302.50 | (52%) 43.5K to 21.0K | |
| 18-Aug-22 5:36 PM View: | Apelian David Director | Eiger BioPharmaceuticals, I... (EIGR) | 16-Aug-22 | Private Sale (Planned) | 5,000 | $9.81 | $49,030.50 | (31%) 16.0K to 11.0K | |
| 14-Mar-22 9:21 PM View: | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | Eiger BioPharmaceuticals, I... (EIGR) | 14-Mar-22 | Private Sale | 1,657 | $5.60 | $9,274.73 | (3%) 62.13K to 60.47K | |
| 14-Mar-22 9:22 PM View: | Ryali Sriram Chief Financial Officer | Eiger BioPharmaceuticals, I... (EIGR) | 14-Mar-22 | Private Sale | 2,266 | $5.60 | $12,683.50 | (5%) 43.83K to 41.57K | |
| 11-Mar-22 9:06 PM View: | Loh Evan Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 75% 8.0K to 14.0K | |
| 11-Mar-22 9:06 PM View: | Sablich Kim Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 11-Mar-22 9:06 PM View: | Murray Christine Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 11-Mar-22 9:06 PM View: | Cory David A President and CEO Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 47,000 | -- | -- | 38% 122.18K to 169.18K | |
| 11-Mar-22 9:06 PM View: | Apelian David Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 11-Mar-22 9:06 PM View: | Atkisson Erik GC & Chief Compliance Officer | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 11-Mar-22 9:06 PM View: | Glenn Jeffrey S Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 3% 232.88K to 238.88K | |
| 11-Mar-22 9:06 PM View: | Ryali Sriram Chief Financial Officer | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 24,000 | -- | -- | 121% 19.83K to 43.83K | |
| 11-Mar-22 9:06 PM View: | Dietz Thomas John Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 16% 37.5K to 43.5K | |
| 11-Mar-22 9:07 PM View: | Sachdev Amit Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 11-Mar-22 9:06 PM View: | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 16,000 | -- | -- | 35% 46.13K to 62.13K | |
| 11-Jan-22 8:59 PM View: | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | Eiger BioPharmaceuticals, I... (EIGR) | 07-Jan-22 | Market Sale | 1,560 | $4.95 | $7,722.16 | (3%) 47.69K to 46.13K | 2% |
| 12-Apr-21 6:10 PM View: | Dietz Thomas John Director | Eiger BioPharmaceuticals, I... (EIGR) | 09-Apr-21 | Market Purchase | 2,500 | $8.49 | $21,220.00 | 7% 35.0K to 37.5K | (1%) |
| 15-Mar-21 7:30 PM View: | Loh Evan Director | Eiger BioPharmaceuticals, I... (EIGR) | 15-Mar-21 | Market Sale | 2,000 | $10.14 | $20,280.00 | (20%) 10.0K to 8.0K | |
| 15-Mar-21 7:33 PM View: | Murray Christine Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 15-Mar-21 7:24 PM View: | Cory David A President and CEO Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 47,000 | -- | -- | 66% 70.85K to 117.85K | |
| 15-Mar-21 7:22 PM View: | Apelian David Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 15-Mar-21 7:27 PM View: | Glenn Jeffrey S Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 5,000 | -- | -- | 2% 227.88K to 232.88K | |
| 15-Mar-21 7:38 PM View: | Ryali Sriram Chief Financial Officer | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 16,250 | -- | -- | 854% 1.9K to 18.15K | |
| 15-Mar-21 7:25 PM View: | Dietz Thomas John Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 5,000 | -- | -- | 17% 30.0K to 35.0K | |
| 15-Mar-21 7:36 PM View: | Patton Stephana Eilene See Remarks | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 11,875 | -- | -- | 196% 6.07K to 17.95K | |
| 15-Mar-21 7:39 PM View: | Sachdev Amit Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 15-Mar-21 7:31 PM View: | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 11,875 | -- | -- | 33% 35.81K to 47.69K | |
| 15-Mar-21 7:41 PM View: | Shaffer James P Chief Business Officer | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 11,875 | -- | -- | 68% 17.42K to 29.3K | |
| 15-Mar-21 7:30 PM View: | Loh Evan Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 11-Jan-21 6:10 PM View: | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | Eiger BioPharmaceuticals, I... (EIGR) | 08-Jan-21 | Market Sale | 1,690 | $11.68 | $19,739.20 | (5%) 37.5K to 35.81K | < 1% |
| 12-Aug-20 6:28 PM View: | Glenn Jeffrey S Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Aug-20 | Market Purchase | 5,000 | $11.42 | $57,102.70 | 2% 222.88K to 227.88K | (12%) |
| 12-Aug-20 6:28 PM View: | Glenn Jeffrey S Director | Eiger BioPharmaceuticals, I... (EIGR) | 11-Aug-20 | Market Purchase | 5,000 | $11.49 | $57,463.50 | 2% 217.88K to 222.88K | (12%) |
| 17-Mar-20 5:16 PM View: | Glenn Jeffrey S Director | Eiger BioPharmaceuticals, I... (EIGR) | 16-Mar-20 | Market Purchase | 30,000 | $5.03 | $150,813.00 | 16% 187.88K to 217.88K | 101% |
| 17-Mar-20 5:17 PM View: | Dietz Thomas John Director | Eiger BioPharmaceuticals, I... (EIGR) | 16-Mar-20 | Market Purchase | 1,000 | $4.95 | $4,950.00 | 3% 29.0K to 30.0K | 104% |
| 13-Mar-20 5:25 PM View: | Glenn Jeffrey S Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-20 | Grant | 5,000 | -- | -- | 3% 182.88K to 187.88K | |
| 13-Mar-20 5:22 PM View: | Dietz Thomas John Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-20 | Grant | 5,000 | -- | -- | 21% 24.0K to 29.0K | |
| 13-Mar-20 5:38 PM View: | Sachdev Amit Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-20 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 13-Mar-20 5:27 PM View: | Loh Evan Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-20 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 13-Mar-20 5:29 PM View: | Murray Christine Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-20 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 13-Mar-20 5:20 PM View: | Apelian David Director | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-20 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 13-Mar-20 5:35 PM View: | Ryali Sriram Chief Financial Officer | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-20 | Grant | 229 | $7.31 | $1,673.99 | 16% 1.4K to 1.63K | |
| 13-Mar-20 5:30 PM View: | Patton Stephana Eilene See Remarks | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-20 | Grant | 820 | $7.31 | $5,994.20 | 20% 4.0K to 4.82K |
